Infosys Ltd share price logo

Infosys Ltd Share Price

(INFY)

₹1422.81.94%

as on 04:01PM, 22 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

🔔 Layoff Alert

Infosys terminates 240 entry-level employees, offering one month's salary and support for external training via NIIT and UpGrad.

Infosys Performance

  • Day's Low

    Day's High

    ₹1,419.3
    Day's Price Range
    ₹1,440
  • 52 Week's Low

    52 Week's High

    ₹1,307
    52-Week Price Range
    ₹2,006.45
1 Month Return-8.9 %
3 Month Return-21.84 %
1 Year Return+ 1.27 %
Previous Close₹1,451.00
Open₹1,440.00
Volume94.00L
Upper Circuit₹1,596.10
Lower Circuit₹1,305.90
Market Cap₹6,02,638.53Cr

Infosys Fundamentals

P/E Ratio

22.5

PEG Ratio

20.27

Market Cap

₹6,02,638.53 Cr

P/B Ratio

7.66

EPS

63.37

Dividend Yield

3.07

Sector

IT - Software

ROE

36.58

Infosys Analyst Rating

based on 42 analysts

BUY

66.67%

Buy

28.57%

Hold

4.76%

Sell

Based on 42 analysts offering long term price targets for Infosys. An average target of ₹1762.81

Source: S&P Global Market Intelligence

Infosys Share analysis

Infosys price forecast by 42 analysts

Upside of21.49%

High

₹2270

Target

₹1762.81

Low

₹1350

Infosys target price ₹1762.81, a slight upside of 21.49% compared to current price of ₹1422.8. According to 42 analysts rating.

Source: S&P Global Market Intelligence

What's happening today

  • img

    Today's Timeline - 22 Apr

    02:47 AM

    -

    Infosys launches a global capability center practice, appointing Deval Shah as leader to enhance GCC capabilities.

    05:30 AM

    -

    Infosys reports Q4 revenue growth of 4.8% in constant currency, with FY26 growth guidance of 0-3%.

    08:30 AM

    -

    HSBC maintains a buy rating on Infosys, setting a target price of Rs 1,700 despite recent revenue misses.

  • img

    Today's Timeline - 22 Apr

    09:30 AM

    -

    Infosys shares fall 1.83%, continuing a downward trend with a 10.59% decline over the past month.

    09:31 AM

    -

    ICICI Securities lowers Infosys target price to Rs 1,470, maintaining a Hold rating amid weak growth outlook.

    03:23 PM

    -

    Infosys offers support measures for 240 terminated entry-level employees, including training and one month's salary.

  • img

    Today's Timeline - 22 Apr

    05:05 PM

    -

    Infosys confirms layoffs of 240 entry-level employees due to assessment failures, providing various support measures.

Key events for Infosys Ltd

  • Infosys Faces Layoffs Amid Growth Challenges and Support Initiatives - 22 Apr, 2025

    Infosys has announced layoffs of 240 entry-level employees while launching a global capability center practice. The company reported modest Q4 growth and received mixed analyst ratings, reflecting ongoing challenges in the IT sector.
  • Infosys Reports Q4 Decline, Shares Rally on Guidance - 21 Apr, 2025

    Infosys reported a 12% decline in Q4 net profit but saw a 3% share price increase due to management's guidance for FY26. Analysts have mixed views, with some maintaining bullish stances while others cut target prices amid ongoing demand challenges.
  • Infosys Faces Decline Amidst Dividend and Growth Concerns - 20 Apr, 2025

    Infosys reported an 11.7% decline in Q4 net profit and projected low revenue growth for FY26. The company announced a final dividend of ₹22 per share and secured $2.6 billion in large deals. Motilal Oswal set a target price of Rs 1650 for the stock.
  • Infosys Announces Dividend Amid Layoffs and Earnings - 19 Apr, 2025

    Infosys declared its highest-ever final dividend of Rs 22 per share for FY25, while also facing criticism for recent layoffs of trainees. The Q4 earnings season commenced with Infosys among the key players. LIC benefits significantly from the dividend payout, indicating strong financial performance despite workforce reductions.
  • Infosys Faces Challenges Amid Weak Q4 Earnings - 18 Apr, 2025

    Infosys reported a significant decline in Q4FY25 net profit and projected weak revenue growth for FY26. The company also announced layoffs and a substantial dividend, while brokerages adjusted target prices downward due to disappointing earnings.
  • Infosys Faces Revenue Decline Ahead of Q4 Results - 16 Apr, 2025

    Infosys is expected to report a decline in revenue and margins in its upcoming Q4 results. The company also announced a partnership with Spark New Zealand and leased significant office space in Pune, indicating ongoing operational expansion despite market challenges.
  • Infosys Faces Challenges Amid CMO Recognition - 15 Apr, 2025

    Infosys CMO Sumit Virmani was named in Forbes' entrepreneurial CMOs list. However, the company anticipates muted Q4 results with profit declines due to market challenges. Shares rose 1.16% ahead of earnings announcement.
  • Infosys Faces Mixed Outlook Ahead of Q4 Earnings - 14 Apr, 2025

    Infosys is set to announce its Q4 FY25 results amid mixed expectations due to global uncertainties. The company has revised its revenue growth guidance and received an upgrade from Susquehanna. Additionally, CMO Sumit Virmani was recognized in Forbes' top CMOs list.
  • Infosys Set for Strong Q4 Earnings Announcement - 13 Apr, 2025

    Infosys is scheduled to announce its Q4 results on April 17, 2025, with expectations of a 14.7% YoY profit increase and 11.2% YoY growth in net sales. The company will also hold investor calls to discuss results and outlook.
  • Infosys Expands Collaborations Amid Stakeholder Changes - 10 Apr, 2025

    Infosys has made significant moves, including acquiring Simplus, extending its partnership with AIB, and facing revenue growth challenges as LIC becomes its largest shareholder.
  • Infosys Extends AIB Partnership Amid Target Price Cut - 09 Apr, 2025

    Infosys announced an extended partnership with AIB for digital transformation while Jefferies cut its target price to ₹1,700. Shares fell 1.76% amid market concerns over IT demand.
  • Infosys Stock Sees Gains Ahead of Earnings - 08 Apr, 2025

    On April 8, 2025, Infosys shares increased by 3.02% in early trading, reflecting positive sentiment as the tech sector prepares for earnings announcements. However, the overall market sentiment remains volatile.
  • Infosys Faces Revenue Decline Amid Market Challenges - 07 Apr, 2025

    Infosys shares dropped 10% amid concerns over weak Q4 revenue growth and EBIT margin contraction due to wage hikes. Analysts recommend a SELL rating, predicting further challenges ahead.
  • Infosys Board Meeting Scheduled for Q4 Results - 06 Apr, 2025

    Infosys has announced a board meeting on April 17, 2025, to discuss and approve its audited financial results for Q4 and the fiscal year ending March 31, 2025, along with a potential final dividend.
  • Infosys Stock Shows Mixed Signals in Market - 05 Apr, 2025

    Infosys exhibits moderate momentum and is fairly valued, with strong financial health and low volatility. However, the sentiment score indicates a bearish outlook.
  • Infosys Faces Revenue Decline Amid Market Concerns - 04 Apr, 2025

    Infosys shares dropped 1.8% as the company anticipates a revenue decline for the March 2025 quarter, with forecasts of modest growth for FY26 amid economic uncertainty.
  • Infosys Faces Legal Challenges and Stock Decline - 03 Apr, 2025

    Infosys experienced a significant stock decline due to investor concerns over a legal battle with Cognizant and external pressures from US tariffs affecting the IT sector.
  • Infosys Launches AI Stats Center Amid Revenue Concerns - 02 Apr, 2025

    Infosys has launched an AI-powered Stats Center in partnership with Formula E to enhance fan engagement. However, Q4 revenue growth may be affected by seasonality and ramp-downs.
  • Infosys Initiatives Amid Stock Decline and Collaborations - 31 Mar, 2025

    Infosys is launching an incubator for employee ideas, preparing for Q4 results, facing a stock decline, and collaborating on Responsible AI with Linux Foundation Networking.
  • Infosys Faces Market Challenges Amid Strategic Moves - 28 Mar, 2025

    Infosys is navigating significant market challenges, with a steep share decline and lowered revenue expectations. However, it continues to pursue strategic partnerships and potential tax benefits.

Insights on Infosys Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 6.36K Cr → 7.03K Cr (in ₹), with an average increase of 3.3% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 30.10% to 30.12% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 17.82% to 18.14% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, HCL Technologies Ltd has given 34.5% return, outperforming this stock by 43.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 13.05% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Wipro Ltd has given 3.2% return, outperforming this stock by 2.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 12.57% to 12.32% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, INFY stock has moved down by -8.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 42.62K Cr → 42.11K Cr (in ₹), with an average decrease of 1.2% per quarter

Infosys News

Dr Reddy's and Lupin Recall Products in US Due to Manufacturing Errors

Princeton-based Dr Reddys Laboratories, Inc is recalling 4,010 bags of Levetiracetam 0.75 pc in Sodium Chloride Injection (1,000 mg/100 mL) in the US due to labelling mix up, USFDA said. The infusion bag is incorrectly labelled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, it added. The company has issued the Class 1 nationwide (US) recall on March 13 this year, the US health regulator noted.22 Apr, 2025 05:45 PM

Dr Reddy's and Lupin Recall Products in US Due to Errors

Dr Reddys Laboratories and Lupin are recalling products in the US market due to labelling and manufacturing errors, respectively, according to the US health regulator. A US-based subsidiary of the Hyderabad-based drug major is recalling certain batches of a generic antiepileptic drug in the US market. Princeton-based Dr Reddys Laboratories, Inc is recalling 4,010 bags of Levetiracetam 0.75 pc in Sodium Chloride Injection (1,000 mg/100 mL) in the US due to labelling mix up, USFDA said. The infusion bag is incorrectly labelled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, it added. The company has issued the Class 1 nationwide (US) recall on March 13 this year, the US health regulator noted. As per the USFDA, a Class I recall pertains to defective products that can cause serious health problems.22 Apr, 2025 05:32 PM

Dr Reddy's and Lupin Recall Drugs in US Due to Errors

Dr Reddys and Lupin Recall Drugs in US Due to Errors. A US-based subsidiary of the Hyderabad-based drug major is recalling certain batches of a generic antiepileptic drug in the US market. Princeton-based Dr Reddys Laboratories, Inc is recalling 4,010 bags of Levetiracetam 0.75 pc in Sodium Chloride Injection (1,000 mg/100 mL) in the US due to labelling mix up. The infusion bag is incorrectly labelled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL. The company has issued the Class 1 nationwide (US) recall on March 13 this year, the US health regulator noted. A Class I recall pertains to defective products that can cause serious health problems.22 Apr, 2025 05:27 PM
View More

Infosys Financials

Value in ₹ crore
DetailsQ'1 24Q'2 24Q'3 24Q'4 24Q'1 25
Revenue₹37,923.00Cr (-)₹39,315.00Cr (↑3.67%)₹40,986.00Cr (↑4.25%)₹41,764.00Cr (↑1.90%)₹40,925.00Cr (↓2.01%)
Net Income₹7,975.00Cr (-)₹6,374.00Cr (↓20.08%)₹6,516.00Cr (↑2.23%)₹6,822.00Cr (↑4.70%)₹7,038.00Cr (↑3.17%)
Net Profit Margin21.03% (-)16.21% (↓22.92%)15.90% (↓1.91%)16.33% (↑2.70%)17.20% (↑5.33%)
Value in ₹ crore
Details2021202220232024
Total Assets₹93,939.00Cr (-)₹99,387.00Cr (↑5.80%)₹1,02,666.00Cr (↑3.30%)₹1,16,947.00Cr (↑13.91%)
Total Liabilities₹22,408.00Cr (-)₹30,081.00Cr (↑34.24%)₹34,921.00Cr (↑16.09%)₹35,771.00Cr (↑2.43%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹15,572.00Cr (-)₹19,902.00Cr (↑27.81%)₹22,096.00Cr (↑11.02%)₹19,169.00Cr (↓13.25%)₹20,787.00Cr (↑8.44%)

Infosys Index Inclusions

SENSEX

₹79,595.59

0.24 (187.09%)

Nifty Services Sector

₹32,299.70

0.18 (58.95%)

NIFTY 100

₹24,770.45

0.18 (44.65%)

S&P BSE Quality

₹1,729.94

0.66 (11.31%)

Nifty100 Low Volatility 30

₹19,244.55

0.06 (11.1%)

S&P BSE 100 LargeCap TMC

₹8,932.18

0.18 (16.41%)

S&P BSE SENSEX 50

₹25,213.72

0.18 (45.46%)

NIFTY IT

₹33,941.05

-0.57 (-194%)

Nifty 200

₹13,416.00

0.28 (37.35%)

S&P BSE Dividend Stability

₹972.70

-0.13 (-1.31%)

Nifty100 Eq Weig

₹31,347.65

0.06 (18.5%)

Nifty100 Quality

₹5,334.60

0.33 (17.45%)

BSE IT Sector

₹33,503.78

-0.6 (-202.7%)

Nifty LargeMidcap 250

₹15,394.25

0.52 (79.1%)

NIFTY 50

₹24,167.25

0.17 (41.7%)

S&P BSE 100 ESG

₹406.09

0.25 (1.02%)

Nifty50 Value 20

₹12,477.10

-0.22 (-27.75%)

BSE Tech

₹16,774.34

-0.9 (-152.63%)

S&P BSE Largecap

₹9,312.83

0.19 (18.03%)

BSE 500

₹34,730.29

0.35 (120.59%)

S&P BSE Low Volatility

₹1,766.34

0.24 (4.16%)

BSE 100

₹25,315.70

0.23 (57.04%)

Nifty 500

₹22,085.15

0.36 (79.4%)

BSE 200

₹10,945.05

0.28 (30.51%)

S&P BSE 250 LargeMidCap

₹10,356.29

0.3 (31.43%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Infosys Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
13.05%
0.00
Foreign Institutions
30.12%
0.07
Mutual Funds
18.14%
1.78
Retail Investors
12.32%
-2.05
Others
26.37%
-0.30

Infosys Key Indicators

Details20202021202220232024
Book Value Per Share (₹)144.63164.7159.7158.03183.52
Details20202021202220232024
Earning Per Share (₹)39.2145.7252.7858.2663.37
Details20202021202220232024
Return On Equity %24.8826.9830.1633.9636.58
Details20202021202220232024
Return On Assets %20.4820.622.2523.4722.43

Infosys Valuation

Infosys in the last 5 years

  • Overview

  • Trends

Lowest (13.79x)

March 23, 2020

Today (22.50x)

April 21, 2025

Industry (30.38x)

April 21, 2025

Highest (38.37x)

December 30, 2021

LowHigh

Infosys Earnings and Dividends

  • Infosys Ltd Earnings Results

    Infosys Ltd’s net profit fell -11.75% since last year same period to ₹7,033Cr in the Q4 2024-2025. On a quarterly growth basis, Infosys Ltd has generated 3.34% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Infosys Ltd Dividends October,2024

    In the quarter ending September 2024, Infosys Ltd has declared dividend of ₹21 - translating a dividend yield of 3.38%.

    Read More about Dividends

Infosys Technicals Summary

Bearish

Neutral

Bullish

Bearish

Infosys Ltd is currently in a Bearish trading position according to technical analysis indicators.

Infosys Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹6,02,638.53 Cr25.21%0.53₹26,248 Cr₹1,53,670 Cr
BUY₹1,27,325.75 Cr40.59%0.54₹4,584 Cr₹35,517 Cr
HOLD₹2,49,712.00 Cr33.42%0.57₹11,112 Cr₹89,760 Cr
HOLD₹4,02,165.17 Cr44.1%0.53₹15,710 Cr₹1,09,913 Cr
BUY₹12,01,783.95 Cr17.54%0.55₹48,797 Cr₹2,55,324 Cr

About Infosys

Infosys Limited is a global leader in the IT services sector, specializing in digital services and consulting. The company was incorporated in 1981 by Narayana Murthy and a group of fellow engineers. Headquartered in Bengaluru, Karnataka, Infosys is registered under the Company Identification Number (CIN) L85110KA1981PLC013115. Infosys offers a wide range of services, including software development, business consulting, information technology, and outsourcing services, helping clients navigate their digital transformation journeys.

Infosys operates in over 50 countries, including the United States, Canada, the United Kingdom, Australia, and various nations in Europe and Asia, providing services to clients across industries such as finance, healthcare, manufacturing, and retail. The company does not have specific sub-brands but offers various products and platforms, such as Finacle, a banking solution, and Infosys Nia, an artificial intelligence platform. Notably, Infosys is recognized for its innovative approach to technology and has been a pioneer in the global IT services industry. Additionally, Infosys has made several strategic acquisitions over the years, including companies like WongDoody and Simplus, to strengthen its capabilities in digital, cloud, and customer experience.

Revenue: ₹40,925.00Cr as on March 2025 (Q1 25)
Net Profit: ₹7,038.00Cr as on March 2025 (Q1 25)
Listing date: 03 Nov, 1994
Chairperson Name: Nandan M Nilekani
OrganisationInfosys
Headquarters
IndustryIT - Software
E-voting on sharesClick here to vote

FAQs on Infosys Ltd

What is Infosys Ltd price today?

Infosys Ltd share price today stands at ₹1422.8, Open: ₹1440, Previous Close: ₹1451, High: ₹1440, Low: ₹1419.3, 52 Week High: ₹2006.45, 52 Week Low: ₹1307.

How to Buy Infosys Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Infosys Ltd shares

What are today's traded volumes of Infosys Ltd?

Today's traded volume of Infosys Ltd(INFY) is 94.00L.

What is today's market capitalisation of Infosys Ltd?

Today's market capitalisation of Infosys Ltd(INFY) is ₹602638.53Cr.

What is the 52 Week High and Low Range of Infosys Ltd?

Infosys Ltd (INFY)
Price
52 Week High
₹2006.45
52 Week Low
₹1307

How much percentage Infosys Ltd is down from its 52 Week High?

Infosys Ltd (INFY) share price is ₹1422.8. It is down -29.09% from its 52 Week High price of ₹2006.45

How much percentage Infosys Ltd is up from its 52 Week low?

Infosys Ltd (INFY) share price is ₹1422.8. It is up 8.86% from its 52 Week Low price of ₹1307